Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19). | Ann Hepatol;22: 100295, 2021. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19).

Li, Xiaofei.

Li X; Department of Infectious Diseases, YiWu Central Hospital, Zhejiang 322000, China. Electronic address: icqwc46@163.com.

Ann Hepatol ; 22: 100295, 2021.

Article in English | MEDLINE | ID: covidwho-947108

Subject(s)

COVID-19; Fatty Liver; Fatty Liver/diagnosis; Fatty Liver/epidemiology; Fibrosis; Humans; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Fatty Liver / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: Ann Hepatol Journal subject: Gastroenterology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Fatty Liver / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: Ann Hepatol Journal subject: Gastroenterology Year: 2021 Document Type: Article